End-to-End Biomarker Discovery Services & Multiomics Analysis
Crown Bioscience provides integrated, compliant biomarker testing, from discovery and assay development to clinical validation. Leverage our CAP-accredited labs and advanced multiomics platforms to turn complex data into confident translational decisions.
Unlock the Full Potential of Your Preclinical and Clinical Data
Crown Bioscience delivers a complete suite of services that spans the entire drug development timeline. Our global network of laboratories operates under the highest standards of quality, including CAP-, CLIA-, and ISO-accredited facilities, ensuring your proprietary data is generated with clinical precision and translational relevance, from exploratory research (RUO) to regulated clinical trials.
Biomarker Services Across the R&D Continuum
Explore our comprehensive biomarker offerings, from discovery through clinical validation.
Access one of the world’s largest PDX and xenograft model collections with integrated omics data. Our preclinical biomarker discovery services leverage this resource to identify and validate predictive signatures in clinically relevant settings.
Flow cytometry, digital pathology, cytokine profiling, proteomics (4D-DIA), NGS, and spatial transcriptomics for robust biomarker measurement and validation.
CAP/CLIA/ISO labs ensure data integrity and compliance by supporting assay development, validation, and regulated biomarker testing for clinical trials.
Accelerate Your Biomarker Discovery
From exploratory discovery to clinical validation, Crown Bioscience provides end-to-end biomarker discovery services to de-risk drug development. Connect with us today to discuss your program.
